2-(purin-9-yl)-tetrahydrofuran-3, 4-diol derivatives
US6610665B1 · kind B1 · utility
5Cited by
2References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 29, 2000 |
| Grant date | Aug 26, 2003 |
| Priority date | — |
| Expiry date | Aug 29, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There are disclosed according to the invention, compounds of formula (I) wherein R1, R2 and R3 are defined in the specification. Additionally, processes of preparing the compounds of formula (I), formulations containing same, and the administration of said compounds or formulations thereof in the treatment of inflammatory diseases are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.